Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
Thoracic Cancer · 2023-09 · 14 (26) · 2715-2731
DOI: 10.1111/1759-7714.15022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 17.07.2023. Verfasst von Qian Wang und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nan…. Hauptthemen laut MEDLINE: Mesothelioma, Malignant, Pleural Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high‐risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) developed a national consensus on the clinical diagnosis and treatment of MPM based on existing clinical research evidence and the opinions of national experts. This consensus aims to promote the homogenization and standardization of MPM diagnosis and treatment in China, covering epidemiology, diagnosis, treatment, and follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
- Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China.
- Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
- Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
- Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
- Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Chunwei Xu, Wenxian Wang, Yongchang Zhang, Zhengbo Song, Shirong Zhang, Ping Zhan, Hongbing Liu, Tangfeng Lv, Liyun Miao, Zhansheng Jiang, Gen Lin, Chengzhi Zhou, Zhengfei Zhu, Xinqing Lin, Jing Cai, Yingying Du
Zitieren
APA
Wang, Q., Xu, C., Wang, W., Zhang, Y., Li, Z., Song, Z., Wang, J., Yu, J., Liu, J., Zhang, S., Cai, X., Li, W., Zhan, P., Liu, H., Lv, T., Miao, L., Min, L., Li, J., Liu, B., …, & Wang, X. (2023). Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma. Thoracic Cancer, 14(26), 2715-2731. https://doi.org/10.1111/1759-7714.15022
Vancouver
Wang Q, Xu C, Wang W, Zhang Y, Li Z, Song Z, et al. Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma. Thoracic Cancer. 2023;14(26):2715-2731. doi:10.1111/1759-7714.15022
BibTeX
@article{Wang2023,
author = {Wang, Qian and Xu, Chunwei and Wang, Wenxian and Zhang, Yongchang and Li, Ziming and Song, Zhengbo and Wang, Jiandong and Yu, Jinpu and Liu, Jingjing and Zhang, Shirong and Cai, Xiuyu and Li, Wen and Zhan, Ping and Liu, Hongbing and Lv, Tangfeng and Miao, Liyun and Min, Lingfeng and Li, Jiancheng and Liu, Baogang and Yuan, Jingping and Jiang, Zhansheng and Lin, Gen and Chen, Xiaohui and Pu, Xingxiang and Rao, Chuangzhou and Lv, Dongqing and Yu, Zongyang and Li, Xiaoyan and Tang, Chuanhao and Zhou, Chengzhi and Zhang, Junping and Guo, Hui and Chu, Qian and Meng, Rui and Liu, Xuewen and Wu, Jingxun and Hu, Xiao and Zhou, Jin and Zhu, Zhengfei and Chen, Xiaofeng and Pan, Weiwei and Pang, Fei and Zhang, Wenpan and Jian, Qijie and Wang, Kai and Wang, Liping and Zhu, Youcai and Yang, Guocai and Lin, Xinqing and Cai, Jing and Feng, Huijing and Wang, Lin and Du, Yingying and Yao, Wang and Shi, Xuefei and Niu, Xiaomin and Yuan, Dongmei and Yao, Yanwen and Huang, Jianhui and Wang, Xiaomin},
title = {Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma},
journal = {Thoracic Cancer},
year = {2023},
volume = {14},
number = {26},
pages = {2715--2731},
doi = {10.1111/1759-7714.15022}
}
EUVIMED